Mail

Mail Peer review: Rejected? Re: “I Hate Your Paper,” 1 the real problem is that publications have lost their purpose. The point of publication is to inform the scientific community of really important findings and to contribute to the growth of knowledge. When I hear—as I typically do when a speaker is being introduced—that some very senior scientist has hundreds of publications, I always wonder: do any of them matter? We

Written byThe Scientist
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Re: “I Hate Your Paper,” 1 the real problem is that publications have lost their purpose. The point of publication is to inform the scientific community of really important findings and to contribute to the growth of knowledge. When I hear—as I typically do when a speaker is being introduced—that some very senior scientist has hundreds of publications, I always wonder: do any of them matter? We have become obsessed with publication for publication’s sake. There are now more journals than ever and still the “top-tiered” journals reject enough papers to fill a library. Here’s a proposal: each scientist has a maximum of 25 papers he or she can publish during a career lifetime. I bet science would not suffer one bit—and all these issues would go away.

Susan Fitzpatrick
James S. McDonnell Foundation
St. Louis, Mo.
susan@jsmf.org

In my opinion, peer review not only works, it is essential. I ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies